Comparison of the effect of immediate (<=6 hours) and early (7-72 hours) angioplasty + epitifibatide on angiographic flow, myocardial perfusion, and infarct size in patients with a first episode of non-ST-elevation myocardial infarction.
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2011
At a glance
- Drugs Eptifibatide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 11 Mar 2011 New trial record